Presentation is loading. Please wait.

Presentation is loading. Please wait.

Paradox of Corneal CXL and Infectious Keratitis: To Do or Not to Do? None of the authors have any financial disclosure to make Vishal Vohra,MS (Presenting.

Similar presentations


Presentation on theme: "Paradox of Corneal CXL and Infectious Keratitis: To Do or Not to Do? None of the authors have any financial disclosure to make Vishal Vohra,MS (Presenting."— Presentation transcript:

1 Paradox of Corneal CXL and Infectious Keratitis: To Do or Not to Do? None of the authors have any financial disclosure to make Vishal Vohra,MS (Presenting Author), Rohit Shetty, DNB, FRCS; Harsha Nagaraj, MS; Luci Kaweri, MD; Chetna Sharma, MS; Natasha K. Pahuja, DOMS Narayana Nethralaya, Bangalore, INDIA

2 PURPOSE To evaluate the dual role of crosslinking both as a treatment modality and a pathogenic factor for microbial keratitis Group 1 To evaluate the efficacy and safety of corneal collagen cross-linking (CXL) in infectious keratitis Group 2 To analyse the profile of microbial keratitis occurring after CXL Group 2 To analyse the profile of microbial keratitis occurring after CXL

3 Riboflavin + UV A radiation Irreversible breaks in DNA / RNA strands Increases the corneal thermal shrinkage temperature Effect on leucocytes Effect on immune response KXL in infectious keratitis: Mechanism Kills microbes Arrests stromal melting Reduces pain and inflammation Reactive Oxygen species

4 Non-healing microbial keratitis Phase 1 of study Conventional CXL 15 eyes of 15 patients Phase 1 of study Conventional CXL 15 eyes of 15 patients Phase 2 of study (ongoing) Accelerated CXL 3 eyes of 3 patients Phase 2 of study (ongoing) Accelerated CXL 3 eyes of 3 patients Not responding to 2 weeks of topical therapy ongoing Prospective, interventional ongoing study METHODOLOGY – GROUP1

5 Soak period 0.1% Riboflavin drops (Medio-Cross D) every 2 minutes for 30 minutes Soak period 0.1% Riboflavin drops (Medio-Cross D) every 2 minutes for 30 minutes Accelerated CXL in 3 patients 9mW/cm 2 for 10 min PROCEDURE Conventional CXL – 15 patients 3mW/cm 2 for 30 minutes Riboflavin + UV-A (365nm) Irradiation Riboflavin + UV-A (365nm) Irradiation

6 RESULTS Total resolution: Seen in 18 patients 8 out of 11 bacterial keratitis (72.73%) showed resolution 3 out of 6 fungal keratitis (50%) showed resolution Acanthoemeba keratitis:  Favourable result but recurrence noted  Can repeat CXL be effective??? Superficial and anterior stromal infiltrates- better response  1 st POD- significantly reduced/ no pain in all patients  ‘Chemical denervation’  Mean time for epithelial healing- 23 days  Mean time for resolution of corneal infiltrate was 33 days

7 Not every story has a Happy Ending…. It is interesting that CXL itself might be a precipitating factor in causing keratitis

8 Group 2 To analyse the profile of microbial keratitis occurring after CXL infectious keratitis post CXL 4 eyes developed infectious keratitis post CXL Etiology - MXRSA) Etiology - moxifloxacin resistant Staphylococcus aureus (MXRSA) These eyes were studied 1715 CXL, 310 TE-CXL and 325 A-CXL over 7 years who underwent CXL 2350 progressive KC patients A Retrospective analysis

9 CaseClinical picture Associated conditions TreatmentProcedureManagement 1Bronchial asthmaInhalational /oral steroids Conventional CXL Femtosecond Endothelial Keratoplasty 2Vernal catarrhTopical steroidsConventional CXL Rigid gas permeable contact lens 3EczemaOral Cyclophospha- mide Conventional CXL Penetrating Keratoplasty 4Vernal catarrhTopical steroidsConventional CXL Amniotic membrane graft, under follow-up Keratitis after CXL - Clinical profile of patients

10 The Question Arises… Cross –linking is treatment of infectious keratitis Cross-linking predisposing to keratitis

11 Pre –operative steroids: ? altered flora Ermis SS, Aktepe OC, Inan UU, Ozturk F, Altindis M. Effect of topical dexamethasone and ciprofloxacin on bacterial flora of healthy conjunctiva. Eye (Lond) Mar; 18(3): SYSTEMIC IMMUNOSUPPRESSION LOCAL STEROID THERAPY LOCAL STEROID THERAPY UVA induced: ? Moxifloxacin resistance Ince D, Zhang X, Hooper DC. Activity of and resistance to moxifloxacin in Staphylococcus aureus. Antimicrob Agents Chemother Apr;47(4):1410-5

12


Download ppt "Paradox of Corneal CXL and Infectious Keratitis: To Do or Not to Do? None of the authors have any financial disclosure to make Vishal Vohra,MS (Presenting."

Similar presentations


Ads by Google